Skip to content

Author

A. Patrikidou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.

This study represents the largest real-world cohort evaluating the referral-to-treatment trajectory in EPT, with patients referred to Gustave Roussy's Drug Development Department between January 1, 2007 and December 31, 2023.

Matthieu Roulleaux Dugage, C. Mazza, P. Matte et al. · 0 citations
Review Open access Sep 2026

PSMA-targeted radioligand therapy with beta emitters in prostate cancer: current evidence, emerging indications, combination strategies, and future directions

Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) has emerged as a major therapeutic advance in metastatic castration-resistant prostate cancer (mCRPC), The phase III VISION trial demonstrated that [177Lu]Lu-PSMA-617 significantly improves overall survival and radiographic progression-free su...

H. Noamen, A. Bekkhoucha, A. Bernard-Tessier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.